We are offering the COVID-19 vaccine to eligible patients based on state and federal guidelines, and as supplies allow. Please do not call us for a vaccine appointment. We are notifying patients individually when they can schedule. Create a MyChart account so we can notify you. Learn more about the COVID-19 vaccine.

If you need help accessing our website, call 855-698-9991
Skip to main content
Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.

Alexander McMeeking, MD

Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.
  • Specialties: Infectious Diseases, Internal Medicine
  • Language: English
  • Phone: 212-929-2629
View Locations

Conditions and Treatments

For Adults
Conditions
  • Lyme disease
  • acquired immunodeficiency syndrome
  • viral hepatitis
  • hepatitis C
  • human immunodeficiency virus
Treatments
  • primary care
  • immunization
  • travel vaccination
Learn more about conditions we treat at NYU Langone:
HIV Infection & AIDS, Hepatitis A, B & C

Positions
Board Certifications
  • American Board of Internal Medicine (Infectious Disease), 1988
  • American Board of Internal Medicine - Internal Medicine, 1985
Education and Training
  • Fellowship, NYU Medical Center, Infectious Diseases, 1987
  • Residency, St. Luke's Roosevelt Hospital, Internal Medicine, 1985
  • MD from UMDNJ, 1982

Is this your profile?

Edit profile

Locations and Appointments

110 East 40th Street, Suite 507
New York, NY 10016

Phone

212-929-2629

View Map

Interests

new therapies for HIV

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

  • A Phase III Randomized Double-blind Placebo-controlled Multicenter Study in Adults to Determine the Safety Efficacy and Immunogenicity of AZD1222 a Non-replicating ChAdOx1 Vector Vaccine for the Prevention of COVID-19

    Learn More

  • A Phase 1/2 Placebo-Controlled Randomized Observer-Blind Dose-Finding Study to Describe the Safety Tolerability Immunogenicity and Potential Efficacy of SARS CoV 2 RNA Vaccine Candidates Against COVID 19 in Healthy Adults

    Learn More

  • Specimen Collection for Infectious Diseases with Public Health Importance

    Learn More
View All Research Studies (4)

Read All Publications (20)